文芳,黄秀桃,刘耀文,李健伟,雷后康,周金年
WEN Fang,HUANG Xiutao,LIU Yaowen,LI Jianwei,LEI Houkang,ZHOU Jinnian

• 1:贵州医科大学附属医院妇产科

摘要(Abstract)：

目的:探讨子痫前期(PE)孕妇胎盘组织中可溶性血管内皮生长因子受体-1(s Flt-1)、胎盘生长因子(PLGF)及胰岛素生长因子-1(IGF-1)的表达和临床意义。方法:收集临床诊断的重度PE孕妇25例和轻度PE15例分别作为重度PE组和轻度PE组,同期30例正常晚期妊娠孕妇作为对照组;取3组孕妇胎盘组织标本,采用免疫组织化学方法检测3组孕妇胎盘组织标本s Flt-1、PLGF及IGF-1的阳性表达水平。结果:轻度及重度PE组孕妇胎盘组织s Flt-1阳性表达高于对照组,且随病情加重而增加(P <0. 05),轻度及重度PE孕妇胎盘组织中PLGF、IGF-1的阳性表达低于对照组,轻度PE组孕妇阳性表达低于重度PE组(P <0. 05);轻度及重度PE组孕妇胎盘组织s Flt-1表达强度等级分别高于对照组(P <0. 05),但PLGF和IGF-1的表达强度等级分别低于对照组(P <0. 05),且轻度组孕妇胎盘组织PLGF和IGF-1的表达强度低于重度组孕妇(P <0. 05)。结论:s Flt-1、PLGF及IGF-1的表达与PE的病情轻重有关,这3项指标可能共同参与了PE病情的发生与发展。
Objective: To investigate the expression and clinical significance of soluble vascular endothelial growth factor receptor-1( s Flt-1),placental growth factor( PLGF) and insulin growth factor-1( IGF-1) in placenta of pregnant women with preeclampsia( PE). Methods: 25 cases with severe PE and 15 cases with mild PE were collected as severe PE group and mild PE group respectively,and 30 normal late pregnant women were selected as the control group. Placental tissue samples from the three groups were taken,and the positive expression and intensity grade of s Flt-1,PLGF,and IGF-1 in placental tissue samples were detected by immunohistochemical method. Results:The positive expression of s Flt-1 in placental tissue of mild and severe PE groups was higher than that of the control group,and increased with the aggravation of the disease( P < 0. 05). The positive expression of PLGF and IGF-1 in placenta of mild and severe PE groups was lower than that of the control group,while it was lower in mild PE group than in severe PE group( P < 0. 05). The expression levels of s Flt-1 in placenta of mild and severe PE groups were higher than those of the control group( P < 0. 05). The expression intensity of PLGF and IGF-1 in placenta of mild and severe PE group were lower than that of severe PE group( P < 0. 05),while it was lower in mild PE group than in severe PE group( P < 0. 05). Conclusion: The expression of s Flt-1,PLGF,and IGF-1 is related to the severity of PE, and the three indexes are involved in the occurrence and development of PE.

关键词(KeyWords)： 免疫组织化学;子痫前期;可溶性血管内皮生长因子受体1;胎盘生长因子;胰岛素生长因子-1;胎盘组织
immunohistochemistry;preeclampsia(PE);soluble vascular endothelial growth factor receptor 1(s Flt-1);placental growth factor(PLGF);insulin growth factor 1(IGF-1);placental tissues

Abstract:

Keywords:

基金项目(Foundation): 贵州省科技计划项目[黔科合LH字(2016)7265]

作者(Author): 文芳,黄秀桃,刘耀文,李健伟,雷后康,周金年
WEN Fang,HUANG Xiutao,LIU Yaowen,LI Jianwei,LEI Houkang,ZHOU Jinnian

DOI: 10.19367/j.cnki.2096-8388.2020.12.013

参考文献(References)：

• [1]NICOLAIDES K H. First-trimester screening for pre-eclampsia:time to act[J]. Ultrasound Obstet Gynecol,2017,50(5):663-664.
• [2]LLURBA E,CRISPI F,VERLOHREN S. Update on the pathophysiological implications and clinical role of angiogenic factors in pregnancy[J]. Fetal Diagn Ther,2015,37(2):81-92.
• [3] CALIMAGLOYOLA A,LERMA E V. Renal complications during pregnancy:In the hypertension spectrum[J]. Dis Mon,2019,65(2):25-44.
• [4]BIRDIR C,DROSTE L,FOX L,et al. Predictive value of s Flt-1,PLGF,s Flt-1/PLGF ratio and PAPP-A for lateonset preeclampsia and IUGR between 32 and 37 weeks of pregnancy[J]. Pregnancy Hypertens, 2018,12:124-128.
• [5]高劲松，沈晶，蒋宇林，等．妊娠中期孕妇血清s Flt-1、Pl GF水平及比值变化预测子痫前期发生的价值[J]．中华妇产科杂志，2014,(1):22-25.
• [6]林莉，杨慧霞．s Flt-1基因的表达调控及作为子痫前期治疗靶点的研究进展[J]．中华妇产科杂志，2019,54(4):271-275.
• [7]陈蕴琪，李婷．高危孕妇中s Flt-1和PLGF预测子痫前期的意义[J]．中国妇幼保健，2018,33(23):5372-5375.
• [8]POWELL M J,VON BEHREN J,NEUHAUSEN S,et al.Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study[J]. Cancer Causes Control,2017,128(10):1027-1032.
• [9]张海芬，贾永森，李晓林，等．子痫前期患者胎盘组织中胰岛素样生长因子-1和胎盘生长因子的表达分析[J]．中国煤炭工业医学杂志，2013,(5):725-728.
• [10]谢幸，苟文丽．妇产科学[M]. 8版．人民卫生出版社，2013.
• [11]陈晶晶，张娅，李敏敏，等．全自动免疫组化仪在标准化染色质量控制中的应用体会[J]．临床与实验病理学杂志，2020,36(5):610-612.
• [12]顾蔚蓉，李笑天．子痫前期的干预与管理[J]．中国实用妇科与产科杂志，2020,36(2):29-32.
• [13]张燕，于学品，汪丛敏，等．NO及VEGF、s FIt-1在早发型子痫前期胎盘中的表达及意义[J]．中国优生与遗传杂志，2017(2):86-87.
• [14]STELLA C L,SIBAI B M. Preeclampsia:diagnosis and management of the atypical presentation[J]. J Matern Fetal Neonatal Med,2006,19(7):381-386.
• [15]贾冬丽，方丽丽，司晓辉．血清PDGF-BB、PIGF和s Flt-1水平检测在预测子痫前期发生中的意义[J]．安徽医药，2018,22(4):685-688.
• [16]徐郁．子痫前期患者血清s Eng与s Flt-1的表达水平及意义[J]．实用临床医药杂志，2016,20(5):174-175.
• [17]郭秋云，李静，冯春华．血清LRRFIP1、s Flt-1/PLGF诊断高龄孕妇并发妊娠期高血压疾病及预后价值[J]．中国计划生育学杂志，2020(7):3.
• [18]王丽婷．HIF-1α、VEGF、s Flt-1在子痫前期患者胎盘组织中的表达及临床意义[J]．中国计划生育学杂志，2020(3):366-369.
• [19]PALMER K R,KAITU'ULINO T J,CANNON P,et al.Maternal plasma concentrations of the placental specific s FLT-1 variant,s FLT-1 e15a,in fetal growth restriction and preeclampsia[J]. J Matern Fetal Neonatal Med,2017,30(6):635-639.
• [20]杨丽萍，侯俊德，申自玮，等．s Flt-1及PLGF的表达与早发型子痫前期的相关性[J]．实用医学杂志，2014,30(14):2263-2264.
• [21]DRAGAN I,WRIGHT D,FIOLNA M,et al. Development of pre-eclampsia within 4 weeks of s Flt-1/Pl GF ratio> 38:comparison of performance at 31-34 vs 35-37weeks'gestation[J]. Ultrasound Obstet Gynecol,2017,49(2):209-212.
• [22]何韵婷，王筱金，王炳顺．子痫前期孕早期预测的研究进展[J]．国际妇产科学杂志，2020,47(4):378-383.
• [23]陈益明，卢莎，顾琳媛，等．早孕期血清s Flt-1、PIGF水平及s Flt-1/PIGF比值与子痫前期的相关性研究[J]．现代实用医学，2018,30(11):1493-1496.
• [24]EREZ O,ROMERO R,MAYMON E,et al. The prediction of late-onset preeclampsia:Results from a longitudinal proteomics study[J]. PLo S One,2017,12(7):e0181468.
• [25]SHAHEEN G,JAHAN S,ULAIN Q,et al. Placental endothelial nitric oxide synthase expression and role of oxidative stress in susceptibility to preeclampsia in Pakistani women[J]. Mol Genet Genomic Med,2020,8(1):e1019.
• [26]GUTIERREZ J A,GOMEZ I,CHIARELLO D I,et al.Role of proteases in dysfunctional placental vascular remodelling in preeclampsia[J]. Biochim Biophys Acta Mol Basis Dis,2020,1866(2):165448.
• [27]INGEC M,GURSOY H G,YILDIZ L,et al. Serum levels of insulin,IGF-1,and IGFBP-1 in pre-eclampsia and eclampsia[J]. Int J Gynaecol Obstet,2004,84(3):214-219.

文章评论(Comment)：